ММВБ 2 961 -0,4%  Nasdaq 10 968 -0,4%  Биткойн 11 879 0,0%  USD/RUB 73,3883 -0,2% 
РТС 1 268 -0,3%  S&P500 3 360 0,3%  Нефть 45,2 0,5%  EUR/RUB 86,1890 -0,2% 
Dow 27 791 1,3%  FTSE100 6 051 0,3%  Золото 2 017 -0,5%  EUR/USD 1,1746 0,1% 

Курс акций Mersana Therapeutics [ISIN: US59045L1061]

купить
продать

Mersana Therapeutics Inc Registered Shs - Профиль

Mersana Therapeutics, Inc. engages in the development and manufacture of antibody drug conjugates to improve patient outcomes in oncology indications. Its product candidates are XMT-1522, which focuses on breast cancer and non-small cell lung cancer (NSCLC) and XMT-1536, which focuses on ovarian cancer and NSCLC. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.

Акционеры

Название Доля (%)
Freefloat80,98
NEA Management Co.11,89
NEA Management Co. LLC11,89
BVF Partners LP10,29
BVF, Inc.8,45
Sarissa Capital Management LP7,86
Sarissa Capital Management LP7,84
Bain Capital Life Sciences LP5,85
Wellington Management Co. LLP4,16
ProQuest Associates IV LLC4,13
OrbiMed Advisors LLC3,96
Vanguard Group, Inc. (Subfiler)3,85
Boxer Capital LLC3,52
Rock Springs Capital Management LP2,93
Ecor1 Capital LLC2,92

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент